Improve breathing with diaphragmatic stimulation
- Trial ID
- NCT04941326
- Official Title
- Investigation of the Effect of Spinal Mobilization and Respiration Techniques on Posture and Respiratory Function in Parkinson's Patients
- Goal
- Improve breathing with diaphragmatic stimulation
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Abant Izzet Baysal University
- Study Type
- INTERVENTIONAL
- Enrollment
- 63 participants
- Conditions
- Parkinson Disease, Camptocormia, Restrictive Lung Disease
- Interventions
- Diaphragmatic stimulation treatment with PNF techniques, Costal mobilization, Breathing exercises, Spinal mobilization, Sham mobilization
Summary For Families
Aiming to ease the severe forward‑bending posture called camptocormia and boost breathing in people with Parkinson's who have restrictive lung signs. The program uses hands-on spinal and rib mobilization, diaphragmatic stimulation paired with PNF techniques that help retrain and activate the diaphragm, and targeted breathing exercises to increase chest wall mobility, improve diaphragm movement, and raise lung volumes; a sham mobilization group is used for comparison. Adults 50 to 85 with Parkinson's who volunteer and have a Modified Medical Research Council dyspnea score above 2 can join, while people with active COVID-19, recent chest or abdominal surgery, diaphragm mobility disorders, conditions that raise intra‑abdominal pressure, or chest masses are excluded.
Locations
- Abant Izzet Baysal University Faculty of Health Science, Bolu, Turkey (Türkiye)
- AIBU Physical Therapy and Rehabiltiation Department, Bolu, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Diaphragmatic stimulation treatment with PNF techniques. Aiming to ease the severe forward‑bending posture called camptocormia and boost breathing in people with Parkinson's who have restrictive lung signs. The program uses hands-on spinal and rib mobilization, diaphragmatic stimulation paired with PNF techniques that help retrain and activate the diaphragm, and targeted breathing exercises to increase chest wall mobility, improve diaphragm movement, and raise lung volumes; a sham mobilization group is used for comparison. Adults 50 to 85 with Parkinson's who volunteer and have a Modified Medical Research Council dyspnea score above 2 can join, while people with active COVID-19, recent chest or abdominal surgery, diaphragm mobility disorders, conditions that raise intra‑abdominal pressure, or chest masses are excluded.
- Who can participate?
- Participants must be between 50 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 years and 4 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.